Related Experiment Video

Updated: Jun 24, 2026

Implantation of the Syncardia Total Artificial Heart
16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

Lipoprotein(a) and accelerated coronary artery disease in cardiac transplant recipients

M Barbir1, S Kushwaha, B Hunt

  • 1Harefield Hospital, Middlesex, UK.

Lancet (London, England)
|December 19, 1992
PubMed

Insights

High levels of serum lipoprotein(a) (Lp(a)) significantly increase the risk of coronary artery disease (CAD) in heart transplant recipients. This finding highlights Lp(a) as a key independent risk factor for accelerated CAD post-transplant.

Area of Science:

  • Cardiology
  • Transplant Medicine
  • Lipidology

Background:

  • Elevated serum lipoprotein(a) (Lp(a)) is a known risk factor for atherosclerotic vascular disease.
  • The association between Lp(a) and accelerated coronary artery disease (CAD) in cardiac transplant recipients remains uninvestigated.

Purpose of the Study:

  • To investigate the relationship between serum Lp(a) concentrations and the development of accelerated CAD in patients who have received a heart transplant.

Main Methods:

  • Serum Lp(a) levels were measured in 130 cardiac transplant recipients during routine follow-up.
  • Annual coronary angiography was performed to assess for CAD.
  • Statistical analysis, including multivariant analysis, was used to determine risk factors.

Main Results:

  • Patients with CAD (n=33) had a significantly higher median Lp(a) concentration (71 mg/dL) compared to those without CAD (n=97, 22 mg/dL).
  • Multivariant analysis identified serum Lp(a) as a significant independent risk factor for CAD.

Conclusions:

  • High serum Lp(a) concentration is an important and independent risk factor for accelerated CAD in cardiac transplant recipients.
  • Monitoring Lp(a) levels may be crucial for managing cardiovascular risk in this patient population.

More Related Videos

Mouse Heterotopic Cervical Cardiac Transplantation Utilizing Vascular Cuffs08:44

Mouse Heterotopic Cervical Cardiac Transplantation Utilizing Vascular Cuffs

Published on: June 23, 2022

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death07:08

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death

Published on: June 6, 2025

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...